Skip to content

TuHURA Biosciences, Inc. HURA Change in Other Assets

Change in Other Assets at other companies

Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$0+100%
Corvus Pharmaceuticals logo
Corvus PharmaceuticalsCRVS
-$88K-7.3%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$1.05M+1,152%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
-$228K+90.9%
Janux Therapeutics logo
Janux TherapeuticsJANX
$1.34M+1,552%
Vera Therapeutics logo
Vera TherapeuticsVERA
$5.14M-12.5%

Other financials

Income statement

See full
Revenue-
Net income-$7.5M-13.1%
EPS (diluted)-$0.13+13.3%

Balance sheet

See full
Cash & equivalents$6.3M+1.3%
Total debt$456.9K+178%
Total equity$23.2M+135%
Total assets$29.7M+103%

Cash flow

See full
Operating cash flow-$4.4M+6.9%
CapEx$48.8K+14.5%
Free cash flow-$4.5M+6.7%

Valuation

See full
Market cap$155.39M+45.8%
Enterprise value$149.54M+52.3%

Returns & leverage

See full
Return on equity-187.2%
Debt / equity0.0×
Current ratio1.2×-1.8×

Where this comes from

Reported directly by TuHURA Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentAssets.

The official record: TuHURA Biosciences, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about TuHURA Biosciences, Inc.'s change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TuHURA Biosciences, Inc.'s change in other assets?
TuHURA Biosciences, Inc. (HURA) reported change in other assets of -$34.9K in Q1 2026.
How has TuHURA Biosciences, Inc.'s change in other assets changed year-over-year?
TuHURA Biosciences, Inc.'s change in other assets increased by 51.3% year-over-year, from -$71.61K to -$34.9K.
What does change in other assets mean?
Change in miscellaneous assets affecting operating cash flow.